Fibrinogen, fibrin and crosslinking in aging arterial thrombi

Thrombosis and Haemostasis

Volumn 84, Issue 1, 2000, Pages 83-87

  McBane II, Robert D ^a,b   Ford, Monique A P ^b,c,d   Karnicki, Krzysztof ^b   Stewart, MaryLou ^b   Owen, Whyte G ^b,c  

^a Mayo Clinic   (United States)

^b Section of Hematology Research   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Arterial thrombosis; Crosslinked fibrin; Fibrin; Fibrinolysis; Platelets

Indexed keywords

FIBRIN; FIBRINOGEN; HIRUDIN; INDIUM 111; MONOCLONAL ANTIBODY; TICK ANTICOAGULANT PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY THROMBOSIS; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CROSS LINKING; CULTURE MEDIUM; FEMALE; FIBRINOGEN METABOLISM; FIBRINOLYSIS; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE FUNCTION; TIME; WESTERN BLOTTING;

EID: 0033937724     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613972     Document Type: Article

References (23)

1. Jorgenson L, Rousell HC, Torstein H, Mustard JF. Resolution and organization of platelet-rich thrombi in carotid arteries of swine. Am J Path 1967; 51: 681-719.
2. Falk E. Dynamics in thrombus formation. Ann NY Acad Sci 1992; 6267: 204-23.
3. Wysokinski W, McBane R, Chesebro JH, Owen WG. Reversibility of platelet thrombosis in vivo. Quantitative analysis in porcine carotid arteries. Thromb Haemost 1996; 76: 1108-13.
4. 2+ concentration. Biochemistry 1995; 34: 9277-81.
5. Reimers HJ, Packham MA, Kinlough-Rathbone RL, Mustard JF. Effect of repealed treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. Br J Haem 1973; 25: 675-89.
6. Kinlough-Rathbone RL, Mustard JF, Perry DW, Dejana E, Cazenave JP, Packham MA, Harfenist EJ. Factors influencing the deaggregation of human and rabbit platelets. Thromb Haemost 1983; 49: 162-7.
7. Kinlough-Rathbone RL, Perry DW, Packham MA, Mustard JF. Deaggregation of human platelets aggregated by thrombin. Thromb Haemost 1985; 53: 42-4.
8. Kinlough-Rathbone RL, Packham MA, Perry DW, Mustard JF, Cattaneo M. Lack of stability of aggregates after thrombin-induced reaggregation of thrombin-degranulated platelets. Thromb Haemost 1992; 67: 453-7.
9. Peerschke EI. Irreversible platelet fibrinogen interactions occur independently of fibrinogen alpha chain degradation and are not mediated by intact platelet membrane glycoprotein IIb-IIIa complexes. J Lab Clin Med 1988; 111: 84-92.
10. Peerschke EI, Wainer JA. Examination of irreversible platelet-fibrinogen interactions. Am J Physiol 1985; 248: C466-72.
11. Kinlough-Rathbone RL, Perry DW, Guccione MA, Rand ML, Packham MA. Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin. Thromb Haemost 1993; 70: 1019-23.
12. Kinlough-Rathbone RL, Packham MA, Guccione MA, Richardson M, Harfenist EJ, Mustard JF. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation. Thromb Haemost 1991; 65: 403-10.
13. Wallis RB. The effect of recombinant hirudin on arterial thrombosis. Adv Exp Med Biol 1993; 340: 237-41.
14. Waxman L, Smith DE, Arcuri KE, Vlasuk GP. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 1990; 248: 593-6.
15. McBane RD, Wysokinski WE, Chesebro JH, Owen WG. Antithrombotic action of endogenous porcine protein C activated with a latent porcine thrombin preparation. Thromb Haemost 1995; 74: 879-85.
16. Dewanjee MK, Rao SA, Didisheim P. Indium-111 tropolone, a new high-affinity platelet label: preparation and evaluation of labeling parameters. J Nucl Med 1981; 22: 981-7.
17. Gerrard JM, Phillips D, Rao G, Plow E, Walz D, Ross R, Harker, White J. Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest 1980; 66: 102-9.
18. Handagama P, Rappolee DA, Werb Z, Levin J, Bainton DF. Platelet alpha-granule fibrinogen, albumin, and immunoglobulin G are not synthesized by rat and mouse megakaryocytes. J Clin Invest 1990; 86: 1364-8.
19. Harfenist EJ, Packham MA, Mustard JF. Reversibility of the association of fibrinogen with rabbit platelets exposed to ADP. Blood 1980; 56: 189-98.
20. Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF. in vitro and in vivo functions of thrombin-treated platelets. Thromb Haemost 1976; 35: 151-66.
21. van Willigen G, Akkerman JW. Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets. Biochem J 1991; 273: 115-20.
22. Smyth SS, Joneckis CC, Parise LV. Regulation of vascular integrins. Blood 1993; 81: 2827-43.
23. Fay WP, Murphy JG, Owen WG. High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi. Arterioscler Thrombos Vasc Biol 1996; 16: 1277-84.